Tingan Chen

Author PubWeight™ 21.74^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.	N Engl J Med	2007	8.28
2	Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling.	J Natl Cancer Inst	2002	2.77
3	Acidity generated by the tumor microenvironment drives local invasion.	Cancer Res	2013	2.63
4	Multiscale modelling of vascular tumour growth in 3D: the roles of domain size and boundary conditions.	PLoS One	2011	1.36
5	Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer.	Cancer	2008	1.15
6	Osteopontin identified as colon cancer tumor progression marker.	C R Biol	2004	0.96
7	Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer.	J Thorac Oncol	2010	0.93
8	The role of tumor tissue architecture in treatment penetration and efficacy: an integrative study.	Front Oncol	2013	0.88
9	In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.	Mol Pharm	2013	0.81
10	Protein kinase C-beta gene variants, pathway activation, and enzastaurin activity in lung cancer.	Clin Lung Cancer	2010	0.78
11	Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In Vivo.	Bioconjug Chem	2015	0.75
12	Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5.	Mol Pharm	2016	0.75